Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis
Norah G. Verbout, Xiaolin Yu, Laura D. Healy, Kevin G. Phillips, Erik I. Tucker, András Gruber, Owen J.T. McCarty, Halina Offner
Dive into the research topics of 'Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis'. Together they form a unique fingerprint.